← NDC auxiliary source history
Current NDC auxiliary source rows
Every current FDA unfinished, excluded, package, product, and compounder source row. Empty or malformed identifiers and report-scoped rows remain addressable by their exact source record and row.
Counts come from the five current base tables. The atomic loader verifies that every base source row has exactly one status projection before publication; directory pages use that verified projection and retain exact base-row detail links.
| Exact source record | Source row | Dataset | Record source | Scope | Status | Status meaning | Product NDC | Package NDC | Product / substance | Application | Reporting period | Normalization | Notes | Source date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
outsourcing:2023-1:138 | 138 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5429 | 26436-5429-1 | Benzocaine; Tetracaine; Lidocaine | 2023-1 | valid | 0 | 2026-10-13 | |
outsourcing:2023-2:138 | 138 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1335 | 72934-1335-2 | Benzoyl Peroxide; Adapalene; Niacinamide | 2023-2 | valid | 0 | 2026-10-13 | |
outsourcing:2024-1:138 | 138 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2024-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2024-2:138 | 138 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2025-1:138 | 138 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bromfenac Sodium; Prednisolone Acetate | 2025-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2025-2:138 | 138 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2435 | 72627-2435-1 | Biotin | 2025-2 | valid | 0 | 2026-10-13 | |
outsourcing:2026-1:138 | 138 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2435 | 72627-2435-1 | Biotin | 2026-1 | valid | 0 | 2026-10-13 | |
compounder:139 | 139 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5028 | 26436-5028-3 | Glutathione | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:139 | 139 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5001 | 26436-5001-5 | Ascorbic Acid | 2019-1 | valid | 0 | 2026-10-13 | |
outsourcing:2019-2:139 | 139 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate; Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2019-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-1:139 | 139 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate; Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2020-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-2:139 | 139 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 62295-3284 | 62295-3284-7 | Betamethasone Sodium Phosphate; Betamethasone Acetate | 2020-2 | valid | 0 | 2026-10-13 | |
outsourcing:2021-1:139 | 139 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69852-216 | 69852-216-10 | Betamethasone Acetate; Betamethasone Sodium Phosphate | 2021-1 | valid | 0 | 2026-10-13 | |
outsourcing:2021-2:139 | 139 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2601 | 72627-2601-4 | Benzyl Alcohol | 2021-2 | valid | 0 | 2026-10-13 | |
outsourcing:2022-1:139 | 139 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69852-880 | 69852-880-10 | Brompheniramine Maleate | 2022-1 | valid | 0 | 2026-10-13 | |
outsourcing:2022-2:139 | 139 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-269 | 70092-269-37 | Bupivacaine Hydrochloride Anhydrous; Fentanyl Citrate | 2022-2 | valid | 0 | 2026-10-13 | |
outsourcing:2023-1:139 | 139 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5200 | 26436-5200-3 | Benzocaine; Tetracaine; Lidocaine | 2023-1 | valid | 0 | 2026-10-13 | |
outsourcing:2023-2:139 | 139 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1327 | 72934-1327-2 | Benzoyl Peroxide; Clindamycin Phosphate; Niacinamide | 2023-2 | valid | 0 | 2026-10-13 | |
outsourcing:2024-1:139 | 139 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-343 | 69194-343-01 | Bevacizumab | 2024-1 | valid | 0 | 2026-10-13 | |
outsourcing:2024-2:139 | 139 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9160 | 71266-9160-2 | Bupivacaine Hydrochloride | 2024-2 | valid | 0 | 2026-10-13 | |
outsourcing:2025-1:139 | 139 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69852-881 | 69852-881-10 | Brompheniramine Maleate | 2025-1 | valid | 0 | 2026-10-13 | |
outsourcing:2025-2:139 | 139 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Biotin | 2025-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2026-1:139 | 139 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1530 | 72934-1530-2 | Brimonidine Tartrate | 2026-1 | valid | 0 | 2026-10-13 | |
compounder:140 | 140 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-4587 | 72682-4587-1 | Glutathione (Preserved) 200mg/ml 30mL | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:140 | 140 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ascorbic Acid | 2019-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2019-2:140 | 140 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate; Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2019-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-1:140 | 140 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-112 | 68985-112-95 | Azithromycin Anhydrous | 2020-1 | valid | 0 | 2026-10-13 | |
outsourcing:2020-2:140 | 140 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2020-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-1:140 | 140 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-1015 | 71266-1015-1 | Betamethasone Sodium Phosphate | 2021-1 | valid | 0 | 2026-10-13 | |
outsourcing:2021-2:140 | 140 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69852-216 | 69852-216-10 | Betamethasone Acetate; Betamethasone Sodium Phosphate | 2021-2 | valid | 0 | 2026-10-13 | |
outsourcing:2022-1:140 | 140 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-970 | 69374-970-50 | Bupivacaine Hydrochloride | 2022-1 | valid | 0 | 2026-10-13 | |
outsourcing:2022-2:140 | 140 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride; Fentanyl Citrate | 2022-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2023-1:140 | 140 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5200 | 26436-5200-1 | Benzocaine; Tetracaine; Lidocaine | 2023-1 | valid | 0 | 2026-10-13 | |
outsourcing:2023-2:140 | 140 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1326 | 72934-1326-2 | Benzoyl Peroxide; Clindamycin Phosphate; Niacinamide | 2023-2 | valid | 0 | 2026-10-13 | |
outsourcing:2024-1:140 | 140 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8006 | 71266-8006-1 | Bevacizumab | 2024-1 | valid | 0 | 2026-10-13 | |
outsourcing:2024-2:140 | 140 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-269 | 70092-269-37 | Bupivacaine Hydrochloride Anhydrous; Fentanyl Citrate | 2024-2 | valid | 0 | 2026-10-13 | |
outsourcing:2025-1:140 | 140 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9160 | 71266-9160-2 | Bupivacaine Hydrochloride | 2025-1 | valid | 0 | 2026-10-13 | |
outsourcing:2025-2:140 | 140 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1530 | 72934-1530-2 | Brimonidine Tartrate | 2025-2 | valid | 0 | 2026-10-13 | |
outsourcing:2026-1:140 | 140 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-947 | 69194-947-01 | Bromfenac Sodium; Moxifloxacin Hydrochloride; Dexamethasone Sodium Phosphate | 2026-1 | valid | 0 | 2026-10-13 | |
compounder:141 | 141 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0419 | 71285-0419-1 | Trophamine 3% / Dextrose 5% With Calcium Gluconate 3.75mEq and Heparin 125 units 250ml in 250ml bag | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:141 | 141 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ascorbic Acid | 2019-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2019-2:141 | 141 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate; Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2019-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-1:141 | 141 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71283-0931 | 71283-0931-1 | Baclofen | 2020-1 | valid | 0 | 2026-10-13 | |
outsourcing:2020-2:141 | 141 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2020-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-1:141 | 141 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-1015 | 71266-1015-2 | Betamethasone Sodium Phosphate | 2021-1 | valid | 0 | 2026-10-13 | |
outsourcing:2021-2:141 | 141 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-3189 | 72627-3189-8 | Betamethasone Dipropionate; Niacinamide; Minoxidil; Pentoxifylline | 2021-2 | valid | 0 | 2026-10-13 | |
outsourcing:2022-1:141 | 141 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-970 | 69374-970-05 | Bupivacaine Hydrochloride | 2022-1 | valid | 0 | 2026-10-13 | |
outsourcing:2022-2:141 | 141 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride; Fentanyl Citrate | 2022-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2023-1:141 | 141 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5200 | 26436-5200-6 | Benzocaine; Tetracaine; Lidocaine | 2023-1 | valid | 0 | 2026-10-13 | |
outsourcing:2023-2:141 | 141 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1331 | 72934-1331-2 | Benzoyl Peroxide; Clindamycin Phosphate; Niacinamide; Tretinoin | 2023-2 | valid | 0 | 2026-10-13 | |
outsourcing:2024-1:141 | 141 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0041 | 81483-0041-5 | Bevacizumab | 2024-1 | valid | 0 | 2026-10-13 | |
outsourcing:2024-2:141 | 141 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 61141-4837 | 61141-4837-1 | Bupivacaine Hydrochloride; Fentanyl Citrate | 2024-2 | valid | 0 | 2026-10-13 | |
outsourcing:2025-1:141 | 141 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-269 | 70092-269-37 | Bupivacaine Hydrochloride Anhydrous; Fentanyl Citrate | 2025-1 | valid | 0 | 2026-10-13 | |
outsourcing:2025-2:141 | 141 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-140 | 69194-140-01 | Bromfenac Sodium; Moxifloxacin Hydrochloride; Dexamethasone Sodium Phosphate | 2025-2 | valid | 0 | 2026-10-13 | |
outsourcing:2026-1:141 | 141 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-140 | 69194-140-01 | Bromfenac Sodium; Moxifloxacin Hydrochloride; Dexamethasone Sodium Phosphate | 2026-1 | valid | 0 | 2026-10-13 | |
compounder:142 | 142 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 83298-517 | 83298-517-10 | Oxytocin | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:142 | 142 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2405 | 72627-2405-1 | Ascorbic Acid | 2019-1 | valid | 0 | 2026-10-13 | |
outsourcing:2019-2:142 | 142 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate; Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2019-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-1:142 | 142 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Benzocaine; Lidocaine Hydrochloride; Tetracaine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-2:142 | 142 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2020-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-1:142 | 142 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 62295-3284 | 62295-3284-7 | Betamethasone Sodium Phosphate; Betamethasone Acetate | 2021-1 | valid | 0 | 2026-10-13 | |
outsourcing:2021-2:142 | 142 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72907-1821 | 72907-1821-3 | Betamethasone Sodium Phosphate | 2021-2 | valid | 0 | 2026-10-13 | |
outsourcing:2022-1:142 | 142 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-078 | 71449-078-51 | Bupivacaine Hydrochloride | 2022-1 | valid | 0 | 2026-10-13 | |
outsourcing:2022-2:142 | 142 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride; Fentanyl Citrate | 2022-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2023-1:142 | 142 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69852-216 | 69852-216-10 | Betamethasone Acetate; Betamethasone Sodium Phosphate | 2023-1 | valid | 0 | 2026-10-13 | |
outsourcing:2023-2:142 | 142 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1329 | 72934-1329-2 | Benzoyl Peroxide; Clindamycin Phosphate; Niacinamide; Tretinoin | 2023-2 | valid | 0 | 2026-10-13 | |
outsourcing:2024-1:142 | 142 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bimatoprost | 2024-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2024-2:142 | 142 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1004 | 73013-1004-1 | Bupivacaine Hydrochloride; Fentanyl Citrate | 2024-2 | valid | 0 | 2026-10-13 | |
outsourcing:2025-1:142 | 142 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 61141-4837 | 61141-4837-1 | Bupivacaine Hydrochloride; Fentanyl Citrate | 2025-1 | valid | 0 | 2026-10-13 | |
outsourcing:2025-2:142 | 142 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-947 | 69194-947-01 | Bromfenac Sodium; Moxifloxacin Hydrochloride; Dexamethasone Sodium Phosphate | 2025-2 | valid | 0 | 2026-10-13 | |
outsourcing:2026-1:142 | 142 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bromfenac Sodium; Prednisolone Acetate | 2026-1 | source_no_ndc | 1 | 2026-10-13 | |||
compounder:143 | 143 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72907-2115 | 72907-2115-5 | Methylprednisolone Acetate | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:143 | 143 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ascorbic Acid | 2019-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2019-2:143 | 143 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate; Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2019-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-1:143 | 143 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Benzocaine; Lidocaine Hydrochloride; Tetracaine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-2:143 | 143 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2020-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-1:143 | 143 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2021-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-2:143 | 143 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2021-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-1:143 | 143 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-2:143 | 143 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride; Fentanyl Citrate | 2022-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2023-1:143 | 143 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69852-216 | 69852-216-10 | Betamethasone Acetate; Betamethasone Sodium Phosphate | 2023-1 | valid | 0 | 2026-10-13 | |
outsourcing:2023-2:143 | 143 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1328 | 72934-1328-2 | Benzoyl Peroxide; Clindamycin Phosphate; Niacinamide; Tretinoin | 2023-2 | valid | 0 | 2026-10-13 | |
outsourcing:2024-1:143 | 143 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9018 | 83826-9018-5 | Bimatoprost; Timolol Maleate | 2024-1 | valid | 0 | 2026-10-13 | |
outsourcing:2024-2:143 | 143 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1028 | 73013-1028-1 | Bupivacaine Hydrochloride; Fentanyl Citrate | 2024-2 | valid | 0 | 2026-10-13 | |
outsourcing:2025-1:143 | 143 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1029 | 73013-1029-1 | Bupivacaine Hydrochloride; Fentanyl Citrate | 2025-1 | valid | 0 | 2026-10-13 | |
outsourcing:2025-2:143 | 143 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bromfenac Sodium; Prednisolone Acetate | 2025-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2026-1:143 | 143 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69852-881 | 69852-881-10 | Brompheniramine Maleate | 2026-1 | valid | 0 | 2026-10-13 | |
compounder:144 | 144 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-079 | 71449-079-59 | Ropivacaine Hydrochloride | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:144 | 144 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2404 | 72627-2404-1 | Ascorbic Acid | 2019-1 | valid | 0 | 2026-10-13 | |
outsourcing:2019-2:144 | 144 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Benzocaine | 2019-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-1:144 | 144 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Benzocaine; Lidocaine Hydrochloride; Tetracaine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-2:144 | 144 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2020-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-1:144 | 144 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2021-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-2:144 | 144 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2021-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-1:144 | 144 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-2:144 | 144 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 61141-4837 | 61141-4837-1 | Bupivacaine Hydrochloride; Fentanyl Citrate | 2022-2 | valid | 0 | 2026-10-13 | |
outsourcing:2023-1:144 | 144 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-1025 | 71266-1025-1 | Betamethasone Sodium Phosphate | 2023-1 | valid | 0 | 2026-10-13 | |
outsourcing:2023-2:144 | 144 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1332 | 72934-1332-2 | Benzoyl Peroxide; Clindamycin Phosphate; Niacinamide; Tretinoin | 2023-2 | valid | 0 | 2026-10-13 | |
outsourcing:2024-1:144 | 144 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9003 | 83826-9003-5 | Bimatoprost; Timolol Maleate; Dorzolamide Hydrochloride; Brimonidine Tartrate | 2024-1 | valid | 0 | 2026-10-13 | |
outsourcing:2024-2:144 | 144 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6591 | 71300-6591-1 | Bupivacaine Hydrochloride; Lidocaine Hydrochloride | 2024-2 | valid | 0 | 2026-10-13 | |
outsourcing:2025-1:144 | 144 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1028 | 73013-1028-1 | Bupivacaine Hydrochloride; Fentanyl Citrate | 2025-1 | valid | 0 | 2026-10-13 | |
outsourcing:2025-2:144 | 144 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69852-881 | 69852-881-10 | Brompheniramine Maleate | 2025-2 | valid | 0 | 2026-10-13 | |
outsourcing:2026-1:144 | 144 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9160 | 71266-9160-2 | Bupivacaine Hydrochloride | 2026-1 | valid | 0 | 2026-10-13 | |
compounder:145 | 145 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-0101 | 70168-0101-1 | Testo100mgCHOL | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:145 | 145 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0001 | 71285-0001-1 | Aspartic Acid; Glutamic Acid | 2019-1 | valid | 0 | 2026-10-13 | |
outsourcing:2019-2:145 | 145 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Benzocaine; Lidocaine Hydrochloride; Tetracaine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-1:145 | 145 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2600 | 72627-2600-5 | Benzyl Alcohol | 2020-1 | valid | 0 | 2026-10-13 | |
outsourcing:2020-2:145 | 145 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2020-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-1:145 | 145 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2021-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-2:145 | 145 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2021-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-1:145 | 145 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-2:145 | 145 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride; Fentanyl Citrate | 2022-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2023-1:145 | 145 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-1025 | 71266-1025-2 | Betamethasone Sodium Phosphate | 2023-1 | valid | 0 | 2026-10-13 | |
outsourcing:2023-2:145 | 145 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1330 | 72934-1330-2 | Benzoyl Peroxide; Clindamycin Phosphate; Niacinamide; Tretinoin | 2023-2 | valid | 0 | 2026-10-13 | |
outsourcing:2024-1:145 | 145 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5084 | 26436-5084-3 | Biotin | 2024-1 | valid | 0 | 2026-10-13 | |
outsourcing:2024-2:145 | 145 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-803 | 69194-803-01 | Bupivacaine Hydrochloride; Lidocaine Hydrochloride | 2024-2 | valid | 0 | 2026-10-13 | |
outsourcing:2025-1:145 | 145 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1004 | 73013-1004-1 | Bupivacaine Hydrochloride; Fentanyl Citrate | 2025-1 | valid | 0 | 2026-10-13 | |
outsourcing:2025-2:145 | 145 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9160 | 71266-9160-2 | Bupivacaine Hydrochloride | 2025-2 | valid | 0 | 2026-10-13 | |
outsourcing:2026-1:145 | 145 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-269 | 70092-269-37 | Bupivacaine Hydrochloride Anhydrous; Fentanyl Citrate | 2026-1 | valid | 0 | 2026-10-13 | |
compounder:146 | 146 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5311 | 26436-5311-1 | LET Topical Gel | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:146 | 146 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0001 | 72196-0001-1 | Aspartic Acid; Glutamic Acid | 2019-1 | valid | 0 | 2026-10-13 | |
outsourcing:2019-2:146 | 146 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Benzocaine; Lidocaine Hydrochloride; Tetracaine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-1:146 | 146 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2600 | 72627-2600-4 | Benzyl Alcohol | 2020-1 | valid | 0 | 2026-10-13 | |
outsourcing:2020-2:146 | 146 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-091 | 71449-091-43 | Bevacizumab | 2020-2 | valid | 0 | 2026-10-13 | |
outsourcing:2021-1:146 | 146 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2021-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-2:146 | 146 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2021-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-1:146 | 146 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0004 | 81483-0004-0 | Bupivacaine Hydrochloride | 2022-1 | valid | 0 | 2026-10-13 | |
outsourcing:2022-2:146 | 146 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-106 | 63037-106-05 | Bupivacaine Hydrochloride; Fentanyl Citrate | 2022-2 | valid | 0 | 2026-10-13 | |
outsourcing:2023-1:146 | 146 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72907-1821 | 72907-1821-3 | Betamethasone Sodium Phosphate | 2023-1 | valid | 0 | 2026-10-13 | |
outsourcing:2023-2:146 | 146 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Benzyl Alcohol | 2023-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2024-1:146 | 146 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Biotin | 2024-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2024-2:146 | 146 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-933 | 69194-933-01 | Bupivacaine Hydrochloride; Lidocaine Hydrochloride | 2024-2 | valid | 0 | 2026-10-13 | |
outsourcing:2025-1:146 | 146 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-138 | 69194-138-01 | Bupivacaine Hydrochloride; Lidocaine Hydrochloride | 2025-1 | valid | 0 | 2026-10-13 | |
outsourcing:2025-2:146 | 146 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-269 | 70092-269-37 | Bupivacaine Hydrochloride Anhydrous; Fentanyl Citrate | 2025-2 | valid | 0 | 2026-10-13 | |
outsourcing:2026-1:146 | 146 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0035 | 81483-0035-0 | Bupivacaine Hydrochloride; Epinephrine Bitartrate | 2026-1 | valid | 0 | 2026-10-13 | |
compounder:147 | 147 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-027 | 71506-027-58 | Norepinephrine Bitartrate | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:147 | 147 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0014 | 71285-0014-2 | Aspartic Acid; Glutamic Acid; Dextrose Monohydrate; Sodium Chloride; Sodium Gluconate; Sodium Acetate; Potassium Chloride; Magnesium Chloride | 2019-1 | valid | 0 | 2026-10-13 | |
outsourcing:2019-2:147 | 147 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Benzocaine; Lidocaine Hydrochloride; Tetracaine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-1:147 | 147 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69852-216 | 69852-216-10 | Betamethasone Acetate; Betamethasone Sodium Phosphate | 2020-1 | valid | 0 | 2026-10-13 | |
outsourcing:2020-2:147 | 147 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-091 | 71449-091-44 | Bevacizumab | 2020-2 | valid | 0 | 2026-10-13 | |
outsourcing:2021-1:147 | 147 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2021-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-2:147 | 147 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2021-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-1:147 | 147 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-269 | 70092-269-37 | Bupivacaine Hydrochloride Anhydrous; Fentanyl Citrate | 2022-1 | valid | 0 | 2026-10-13 | |
outsourcing:2022-2:147 | 147 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-107 | 63037-107-05 | Bupivacaine Hydrochloride; Fentanyl Citrate | 2022-2 | valid | 0 | 2026-10-13 | |
outsourcing:2023-1:147 | 147 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2023-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2023-2:147 | 147 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69852-216 | 69852-216-10 | Betamethasone Acetate; Betamethasone Sodium Phosphate | 2023-2 | valid | 0 | 2026-10-13 | |
outsourcing:2024-1:147 | 147 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5541 | 26436-5541-1 | Boric Acid | 2024-1 | valid | 0 | 2026-10-13 | |
outsourcing:2024-2:147 | 147 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5500 | 26436-5500-1 | Buprenorphine Hydrochloride | 2024-2 | valid | 0 | 2026-10-13 | |
outsourcing:2025-1:147 | 147 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5500 | 26436-5500-1 | Buprenorphine Hydrochloride | 2025-1 | valid | 0 | 2026-10-13 | |
outsourcing:2025-2:147 | 147 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1004 | 73013-1004-1 | Bupivacaine Hydrochloride; Fentanyl Citrate | 2025-2 | valid | 0 | 2026-10-13 | |
outsourcing:2026-1:147 | 147 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1004 | 73013-1004-1 | Bupivacaine Hydrochloride; Fentanyl Citrate | 2026-1 | valid | 0 | 2026-10-13 | |
compounder:148 | 148 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71170-020 | 71170-020-05 | Succinylcholine Cl 100 mg per 5 mL Syringe (20 mg/mL) | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:148 | 148 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-935 | 69374-935-03 | Atropine | 2019-1 | valid | 0 | 2026-10-13 | |
outsourcing:2019-2:148 | 148 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Benzocaine; Lidocaine; Tetracaine | 2019-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-1:148 | 148 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Betamethasone Acetate; Betamethasone Sodium Phosphate | 2020-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-2:148 | 148 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-091 | 71449-091-35 | Bevacizumab | 2020-2 | valid | 0 | 2026-10-13 | |
outsourcing:2021-1:148 | 148 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2021-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-2:148 | 148 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2021-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-1:148 | 148 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride; Fentanyl Citrate | 2022-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-2:148 | 148 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride; Lidocaine Hydrochloride | 2022-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2023-1:148 | 148 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2023-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2023-2:148 | 148 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69852-216 | 69852-216-10 | Betamethasone Acetate; Betamethasone Sodium Phosphate | 2023-2 | valid | 0 | 2026-10-13 | |
outsourcing:2024-1:148 | 148 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5612 | 26436-5612-1 | Boric Acid | 2024-1 | valid | 0 | 2026-10-13 | |
outsourcing:2024-2:148 | 148 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-4365 | 72934-4365-3 | Calcipotriene; Clobetasol Propionate | 2024-2 | valid | 0 | 2026-10-13 | |
outsourcing:2025-1:148 | 148 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-4618 | 72934-4618-3 | Calcipotriene; Clobetasol Propionate | 2025-1 | valid | 0 | 2026-10-13 | |
outsourcing:2025-2:148 | 148 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1028 | 73013-1028-1 | Bupivacaine Hydrochloride; Fentanyl Citrate | 2025-2 | valid | 0 | 2026-10-13 | |
outsourcing:2026-1:148 | 148 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1028 | 73013-1028-1 | Bupivacaine Hydrochloride; Fentanyl Citrate | 2026-1 | valid | 0 | 2026-10-13 | |
compounder:149 | 149 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-131 | 71449-131-15 | Dexmedetomidine Hydrochloride | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:149 | 149 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-6000 | 71286-6000-1 | Atropine Sulfate | 2019-1 | valid | 0 | 2026-10-13 | |
outsourcing:2019-2:149 | 149 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Benzocaine; Lidocaine; Tetracaine | 2019-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-1:149 | 149 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71283-0620 | 71283-0620-2 | Betamethasone Acetate; Betamethasone Sodium Phosphate | 2020-1 | valid | 0 | 2026-10-13 | |
outsourcing:2020-2:149 | 149 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2020-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-1:149 | 149 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2021-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-2:149 | 149 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2021-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-1:149 | 149 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 61141-4837 | 61141-4837-1 | Bupivacaine Hydrochloride; Fentanyl Citrate | 2022-1 | valid | 0 | 2026-10-13 | |
outsourcing:2022-2:149 | 149 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride; Lidocaine Hydrochloride | 2022-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2023-1:149 | 149 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0041 | 81483-0041-5 | Bevacizumab | 2023-1 | valid | 0 | 2026-10-13 | |
outsourcing:2023-2:149 | 149 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-4343 | 72934-4343-8 | Betamethasone Dipropionate; Minoxidil | 2023-2 | valid | 0 | 2026-10-13 | |
outsourcing:2024-1:149 | 149 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1396 | 72934-1396-2 | Brimonidine Tartrate | 2024-1 | valid | 0 | 2026-10-13 | |
outsourcing:2024-2:149 | 149 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-625 | 69194-625-01 | Calcium Chloride | 2024-2 | valid | 0 | 2026-10-13 | |
outsourcing:2025-1:149 | 149 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-625 | 69194-625-01 | Calcium Chloride | 2025-1 | valid | 0 | 2026-10-13 | |
outsourcing:2025-2:149 | 149 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1029 | 73013-1029-1 | Bupivacaine Hydrochloride; Fentanyl Citrate | 2025-2 | valid | 0 | 2026-10-13 | |
outsourcing:2026-1:149 | 149 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1029 | 73013-1029-1 | Bupivacaine Hydrochloride; Fentanyl Citrate | 2026-1 | valid | 0 | 2026-10-13 | |
compounder:150 | 150 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2573 | 72934-2573-2 | Rocelix | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:150 | 150 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate | 2019-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2019-2:150 | 150 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2600 | 72627-2600-4 | Benzyl Alcohol | 2019-2 | valid | 0 | 2026-10-13 | |
outsourcing:2020-1:150 | 150 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71283-0621 | 71283-0621-5 | Betamethasone Acetate; Betamethasone Sodium Phosphate | 2020-1 | valid | 0 | 2026-10-13 | |
outsourcing:2020-2:150 | 150 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8005 | 71266-8005-2 | Bevacizumab | 2020-2 | valid | 0 | 2026-10-13 | |
outsourcing:2021-1:150 | 150 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8006 | 71266-8006-1 | Bevacizumab | 2021-1 | valid | 0 | 2026-10-13 | |
outsourcing:2021-2:150 | 150 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2021-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-1:150 | 150 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride; Fentanyl Citrate | 2022-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-2:150 | 150 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine; Fentanyl Citrate | 2022-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2023-1:150 | 150 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2023-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2023-2:150 | 150 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-4350 | 72934-4350-8 | Betamethasone Dipropionate; Minoxidil | 2023-2 | valid | 0 | 2026-10-13 | |
outsourcing:2024-1:150 | 150 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bromfenac Sodium; Moxifloxacin Hydrochloride; Dexamethasone Sodium Phosphate | 2024-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2024-2:150 | 150 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Calcium Chloride Anhydrous | 2024-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2025-1:150 | 150 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Calcium Chloride | 2025-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2025-2:150 | 150 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 61141-4837 | 61141-4837-1 | Bupivacaine Hydrochloride; Fentanyl Citrate | 2025-2 | valid | 0 | 2026-10-13 | |
outsourcing:2026-1:150 | 150 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-138 | 69194-138-01 | Bupivacaine Hydrochloride; Lidocaine Hydrochloride | 2026-1 | valid | 0 | 2026-10-13 | |
compounder:151 | 151 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72055-009 | 72055-009-01 | Norepinephrine Bitartrate | 2024-2 | valid | 0 | 2026-09-18 |